Lombardi Cancer Center at Georgetown University Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Lombardi Cancer Center at Georgetown University Medical Center has participated in 38 clinical trials.
Therapeutic areas: Breast Cancer, Endometrial Cancer, Lymphoma.
Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, Georgetown University.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lombardi Cancer Center at Georgetown University Medical Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lombardi Cancer Center at Georgetown University Medical Center has 38 clinical trials on record. Their work covers Breast Cancer, Endometrial Cancer, Lymphoma.
Yes — Lombardi Cancer Center at Georgetown University Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.